Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 12 of 12 for “"B-cell activating factor (BAFF)"”.

  1. Impact of B cell Activating Factor (BAFF) on Autoimmune Neuroinflammation

    … disease, is mediated by myelin-reactive CD4+ T cells. Anti-CD20 B cell depletion therapies are highly effective at treating MS, but the mechanisms underpinning this protection are poorly defined. Paradoxically, removal of B lineage cells by targeting B cell survival factors, including the B cell …

    toronto-retro Repository record for Impact of B cell Activating Factor (BAFF) on Autoimmune Neuroinflammation (opens in a new tab)

  2. Συμμετοχή του παράγοντα ενεργοποίησης Β-κυττάρων (B-cell activating factor-BAFF) στη σχετική με τη ρευματοειδή αρθρίτιδα και το σύνδρομο Sjogren Αθηροσκλήρωση

    … pathogenetic mechanism. Even if traditional risk factors, such as hypertension, diabetes mellitus, hyperlipidemia, smoking, obesity and physical inactivity are found more frequently in the patient group, this imbalance does not seem to substantially explain mortality rate differences. Large cohort …

    greece Repository record for Συμμετοχή του παράγοντα ενεργοποίησης Β-κυττάρων (B-cell activating factor-BAFF) στη σχετική με τη ρευματοειδή αρθρίτιδα και το σύνδρομο Sjogren Αθηροσκλήρωση (opens in a new tab)

  3. Ο ρόλος του γονιδίου και της πρωτεΐνης TACI σε ασθενείς με σαρκοείδωση

    … is presumed to be dictated by enhanced T cell immunity deregulation, however studies have suggested that patients with sarcoidosis exhibit an augmented humoral immune response manifested by increased amount of circulating immunoglobulins and the presence of autoantibodies. However the …

    greece Repository record for Ο ρόλος του γονιδίου και της πρωτεΐνης TACI σε ασθενείς με σαρκοείδωση (opens in a new tab)

  4. INVESTIGATING B CELLS IN COMPARTMENTALIZED AND PERIPHERAL INFLAMMATION DURING CENTRAL NERVOUS SYSTEM AUTOIMMUNITY

    … of the brain and spinal cord whereby immune cells collaborate to mediate demyelination. B cell depleting therapies (anti-CD20) are used to treat both MS and MOGAD, though it remains unknown whether treatment success can be attributed to targeting of peripheral B cells or those localized to …

    toronto-retro Repository record for INVESTIGATING B CELLS IN COMPARTMENTALIZED AND PERIPHERAL INFLAMMATION DURING CENTRAL NERVOUS SYSTEM AUTOIMMUNITY (opens in a new tab)

  5. Brain-reactive antibodies in inflammatory and degenerative diseases of the central nervous system (CNS)

    … anti-cluster of differentiation 20 (CD20) cell depletion therapy, ocrelizumab, beyond its effect on B-cell depletion. We propose that, in addition to targeting CD20-positive B cells, the elimination of CD20-positive T cells and changes in the levels of B-cell regulatory factors also play a …

    lmu-germany Repository record for Brain-reactive antibodies in inflammatory and degenerative diseases of the central nervous system (CNS) (opens in a new tab)

  6. B CELL ACTIVATING FACTOR AND MATRIX METALLOPROTEINASE-2 AS NOVEL MODULATORS OF INSULIN RESISTANCE AND GLUCOSE UTILIZATION

    … tissue mediated by the infiltration of immune cells. In recent years, many studies have highlighted the importance of understanding the interplay between the body's metabolic state and the activation of the immune system in type 2 diabetes. Here, we identify novel roles for B cell-activating …

    ecu Repository record for B CELL ACTIVATING FACTOR AND MATRIX METALLOPROTEINASE-2 AS NOVEL MODULATORS OF INSULIN RESISTANCE AND GLUCOSE UTILIZATION (opens in a new tab)

  7. Molecular and immunological mechanisms of B cell activating factor-driven B cell dysregulation in CVID

    … with profound pulmonary infiltration of T and B cells, granulomatous inflammation, and dysregulated B cell activation, suggesting that intrinsic immune abnormalities contribute to its development. B cell depletion therapy ameliorates disease in a subset of CVID ILD, yet variability in treatment …

    bu Repository record for Molecular and immunological mechanisms of B cell activating factor-driven B cell dysregulation in CVID (opens in a new tab)

  8. INVESTIGATING THE IMMUNOBIOLOGY OF IgE+ B CELLS AND REGULATORY B CELLS IN ALLERGIC ASTHMA

    … (-eg- histamine) released by granulocytic cells (-eg- mast cells and basophils). However, immunoglobulin E (IgE) antibody is also necessary for the initiation of the allergic cascade, and IgE is produced and released exclusively by memory B cells and plasma cells. Allergen crosslinking of …

    mcmaster Repository record for INVESTIGATING THE IMMUNOBIOLOGY OF IgE+ B CELLS AND REGULATORY B CELLS IN ALLERGIC ASTHMA (opens in a new tab)

  9. Local and systemic effects of adipocyte-secreted factors in breast cancer

    … progresses in response to multiple environmental factors, including local microenvironmental factors within the breast and systemic markers in circulation. Obesity affects one third of all New Zealand adults and is known to negatively impact breast cancer outcomes. Epidemiological studies have …

    liege Repository record for Local and systemic effects of adipocyte-secreted factors in breast cancer (opens in a new tab)